CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
12 hedge funds and large institutions have $1.03M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Jane Street
New York
|
+$190K |
2 |
DF
Dunhill Financial
London,
United Kingdom
|
+$2.41K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$151K |
2 |
Morgan Stanley
New York
|
-$20.3K |
3 |
UBS Group
Zurich,
Switzerland
|
-$13.8K |
4 |
![]()
Focus Partners Wealth
Boston,
Massachusetts
|
-$4.26K |
5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.77K |